How Often to Take Mounjaro: Your Weekly Dosing Guide

Last reviewed: July 12, 2026

Last updated: July 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, marketed as Mounjaro for weight management, follows a specific weekly injection protocol designed to minimize side effects while building therapeutic benefit. Unlike daily medications, this once-weekly GLP-1 receptor agonist and GIP receptor agonist combination allows consistent dosing patterns that most patients find manageable. Understanding your injection schedule and dose progression is key to getting the most from treatment.

Tirzepatide Injection Frequency: Once Weekly

Tirzepatide is injected subcutaneously (under the skin) exactly once per week, on the same day each week. This consistent seven-day cycle allows your body to maintain steady hormone signaling through GLP-1 and GIP receptors, which regulate appetite and blood sugar. Most patients choose a convenient day—such as Monday morning or Sunday evening—and set a phone reminder to build the habit.

The once-weekly schedule differs fundamentally from older diabetes medications requiring daily dosing or multiple daily injections. One injection per week reduces medication burden and improves real-world adherence, meaning you're more likely to stay consistent with treatment. Weekly dosing also simplifies travel, work schedules, and social routines compared to daily pill regimens.

Tirzepatide Dose Escalation: 16–20 Week Titration Protocol

Treatment begins at a low starting dose (0.2.5 mg weekly) to allow your system to adapt and minimize nausea or gastrointestinal side effects. Over the following 16–20 weeks, your dose increases in four-step increments—0.5 mg, 1 mg, 1.5 mg, and up to 2.5 mg—based on your tolerance and response. Each step typically lasts four weeks, giving your body time to adjust before the next increase.

This gradual escalation strategy is backed by clinical trial data showing that slow titration reduces dropout rates due to side effects while maintaining steady weight loss momentum. Your PlexusDx provider monitors your progress at each step and may pause, adjust the timeline, or modify the dose based on your individual tolerance and goals. The key principle: your dose may need to go up, but your price stays the same with PlexusDx's flat-rate monthly pricing.

Maintaining Your Weekly Tirzepatide Routine

Once you reach your target dose, you'll continue the same one-injection-per-week schedule indefinitely, or as directed by your treatment provider. Consistency matters—injecting on the same day and time each week helps maintain stable hormone levels and predictable appetite suppression. Missing a dose by a day or two typically does not cause problems, but resuming your regular schedule as soon as possible is recommended.

Tracking your injection date in a calendar, phone app, or medication journal helps prevent missed doses and ensures you refill your prescription on time. PlexusDx compounded tirzepatide arrives in pre-filled pens or vials with clear instructions; storing them in the refrigerator between 2–8°C (36–46°F) preserves stability. Most patients develop a routine within 2–3 weeks and report that weekly injections become second nature.

Personalizing Your Tirzepatide Protocol with Genetic Testing

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients carrying specific genetic variants may benefit from dose adjustments, extended titration timelines, or combination therapies like GLP-Squared (semaglutide plus tirzepatide). Genetic insights also help identify whether oral versus injectable formulations may work better for your biology. PlexusDx uses this data to optimize your weekly injection protocol and maximize weight loss outcomes without guesswork.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I change my injection day each week, or does it have to be the same day?

Injecting on the same day each week provides the most consistent hormone levels and predictable appetite suppression. If you must shift your injection day occasionally, try to keep it within 1–2 days of your usual schedule. Discuss larger schedule changes with your PlexusDx provider.

What happens if I miss a weekly tirzepatide injection?

Missing one injection typically does not cause immediate problems, but appetite may return within a few days. Resume your regular injection schedule as soon as possible. If you miss more than one dose in a row, contact your PlexusDx provider for guidance before restarting.

How long does the dose escalation phase last, and when will I reach my maintenance dose?

Most patients complete the four-step dose escalation over 16–20 weeks, reaching a maintenance dose of 1.5–2.5 mg weekly. Your PlexusDx provider adjusts the timeline based on your tolerance and weight loss response. Some patients plateau at lower doses if they achieve their goals earlier.

Does PlexusDx's compounded tirzepatide cost change as my dose increases?

No. PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan and remain flat across all dose levels—your dose may need to go up, but your price won't. All tiers (commitment options) maintain flat-rate pricing, with no per-dose surcharges.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.